Global law firm White & Case LLP has advised Merck KGaA (Merck), a leading science and technology company, on the acquisition of the MAST platform (Modular Automated Sampling Technology) from Lonza.
The MAST platform is an automated, aseptic bioreactor sample collection system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. It was developed in Bend, Oregon, in the US. The acquisition of the MAST platform by Merck expands Merck's bioprocess portfolio and makes it the first company to offer a fully integrated ecosystem for advanced process technologies.
Merck, headquartered in Darmstadt, Germany, is a leading science and technology company that operates across healthcare, life science and electronics. The company employs approximately 60,000 people and had sales of €19.7 billion in 2021 in 66 countries.
Lonza was founded in Switzerland in 1897 and employs approximately 16,000 people across five continents.
The White & Case team which advised on the transaction was led by partner Stefan Koch (Frankfurt) and included partners Keith Schomig (Washington, DC), Victoria Rosamond (New York) and Bodo Bender (Frankfurt), counsel Samantha Rozell (New York) and associates Caitlin Powell Gimpel (Milan), Christian Sperling (Frankfurt) and Tyrone Crawford (Washington, DC).
For more information please speak to your local media contact.